Anthony Mancini Sells 1,764 RVMD Shares at $196.94 Each

On September 23, 2026, Anthony Mancini sold 1,764 shares of Revolution Medicines, Inc. (ticker: RVMD) at a price of $196.94 per share, for a total value of $347,402, as reported in the Form 4 filed with the SEC.

Who is Anthony Mancini and What is His Real Role at Revolution Medicines, Inc.

Anthony Mancini appears in the Form 4 as an insider, with the notation "See Remarks" for the description of his position. This notation means that details regarding his role are provided in the remarks section of the official document, which is not reproduced here. In practice, designated insiders in SEC filings are typically executives, board members, or employees with direct access to material, unpublicized information that could impact the stock price.

Within a publicly traded company like Revolution Medicines, individuals in leadership or board roles have privileged access to strategic decisions, clinical trial results, licensing agreements, and financial projections. This information, not yet available to the market, is considered "material" under U.S. regulations. Therefore, each transaction executed by such an insider must be disclosed promptly to ensure transparency for investors.

While the exact role of Anthony Mancini is not explicitly detailed in the provided excerpts, the mere fact that he is listed as an insider implies sufficient internal knowledge to comply with the SEC's Form 4 filing requirements.

Transaction Details: 1,764 Shares at $196.94 Each

The filing indicates that the transaction involved 1,764 shares, each sold at $196.94. The date of record for the transaction is September 23, 2026, which also corresponds to the filing date of the Form 4. The total value of the sale amounts to $347,402, calculated by multiplying the number of shares by the per-share price. It is important not to confuse the per-share price ($196.94) with the total value ($347,402), two distinct figures appearing in the document.

Why Insiders Sell Their Shares - Possible Reasons

Share sales by insiders can stem from several legitimate motivations. Portfolio diversification is a common reason: an executive might want to reduce their exposure to a single company to balance overall risk. Tax planning is also a factor; realizing gains may be timed to take advantage of favorable tax brackets or to meet tax payment obligations.

Personal liquidity needs, such as funding real estate purchases, educational expenses, or significant expenses, may lead an insider to liquidate a portion of their shares. Additionally, the sale could reflect internal treasury management strategies, where the executive decides to monetize a portion of their holdings to reinvest in other projects or meet contractual obligations.

Finally, while the transaction is characterized as a "downward signal" due to it being a sale, it is important to nuance this: an insider may sell without anticipating a price decline, simply because the current valuation meets their financial objectives. No element of the filing allows definitive conclusions about underlying market intentions.

How Individual Investors Track Form 4 Filings

Form 4 filings are freely accessible on the SEC's EDGAR website, where each filing is indexed by the company's CIK number and transaction date. Financial data platforms such as Bloomberg, Yahoo Finance, or specialized services like OpenInsider aggregate this information and offer real-time alerts when an insider executes a transaction.

For individual investors, it is advisable to regularly review Form 4 filings to identify trading trends among executives. However, it is important to remember that the available information is limited to the transaction date and does not include the insider's personal motivations. The data should therefore be integrated into a broader analysis, including the company's financial results, sector outlooks, and valuation metrics.

In practice, investors can create watchlists of key insiders, set up notifications via the mentioned tools, and compare transaction volumes to subsequent price movements. While this approach is valuable, it does not replace rigorous fundamental analysis and should be used as a complementary information source, not as a sole decision-making signal for buying or selling.